BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22032582)

  • 1. Core-binding factor acute myeloid leukemia.
    Sangle NA; Perkins SL
    Arch Pathol Lab Med; 2011 Nov; 135(11):1504-9. PubMed ID: 22032582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Core-binding factor abnormalities involving chromosome 16 in acute myeloid leukaemia: prognostic and therapeutic implications.
    Panigrahi C; Tikare N; Das PK; Padhi S
    BMJ Case Rep; 2023 Aug; 16(8):. PubMed ID: 37591621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Core Binding Factor Leukemia: Chromatin Remodeling Moves Towards Oncogenic Transcription.
    Beghini A
    Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31817911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute myeloid leukemia with rare recurring translocations-an overview of the entities included in the international consensus classification.
    Rørvik SD; Torkildsen S; Bruserud Ø; Tvedt THA
    Ann Hematol; 2024 Apr; 103(4):1103-1119. PubMed ID: 38443661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in molecular genetics and treatment of core-binding factor acute myeloid leukemia.
    Mrózek K; Marcucci G; Paschka P; Bloomfield CD
    Curr Opin Oncol; 2008 Nov; 20(6):711-8. PubMed ID: 18841055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal eosinophils with immature eosinophilic granules in chronic myeloid leukemia in accelerated phase.
    Cai J; Ji P; Tomassetti S; Qing X
    Clin Case Rep; 2021 Sep; 9(9):e04783. PubMed ID: 34512985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Case of a Patient with Therapy-related Core Binding Factor (CBF) Acute Myeloid Leukemia (CBF-AML).
    Lee E; Zavala A; Murthy A; Li L; Ahmed T; Fernicola P; Giordano C; Poerio C; Zaslav AL; Evans G; Tirado CA
    J Assoc Genet Technol; 2024; 50(1):19-23. PubMed ID: 38447191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute myeloid leukemia with t (5;12) (q33;p13) and inv (3) (q21q26) : a case report and literature review].
    Zhou NC; Li GH; Chen RA; Liu L
    Zhonghua Xue Ye Xue Za Zhi; 2018 Mar; 39(3):248-250. PubMed ID: 29562475
    [No Abstract]   [Full Text] [Related]  

  • 9. Core-binding factor acute myeloid leukemia: can we improve on HiDAC consolidation?
    Paschka P; Döhner K
    Hematology Am Soc Hematol Educ Program; 2013; 2013():209-19. PubMed ID: 24319183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Core-binding factor acute myeloid leukemia in first relapse: a retrospective study from the French AML Intergroup.
    Hospital MA; Prebet T; Bertoli S; Thomas X; Tavernier E; Braun T; Pautas C; Perrot A; Lioure B; Rousselot P; Tamburini J; Cluzeau T; Konopacki J; Randriamalala E; Berthon C; Gourin MP; Recher C; Cahn JY; Ifrah N; Dombret H; Boissel N
    Blood; 2014 Aug; 124(8):1312-9. PubMed ID: 25006122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Core binding factor acute myeloid leukaemia and c-KIT mutations.
    Riera L; Marmont F; Toppino D; Frairia C; Sismondi F; Audisio E; Di Bello C; D'Ardia S; Di Celle PF; Messa E; Inghirami G; Vitolo U; Pich A
    Oncol Rep; 2013 May; 29(5):1867-72. PubMed ID: 23467883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive mutational profiling of core binding factor acute myeloid leukemia.
    Duployez N; Marceau-Renaut A; Boissel N; Petit A; Bucci M; Geffroy S; Lapillonne H; Renneville A; Ragu C; Figeac M; Celli-Lebras K; Lacombe C; Micol JB; Abdel-Wahab O; Cornillet P; Ifrah N; Dombret H; Leverger G; Jourdan E; Preudhomme C
    Blood; 2016 May; 127(20):2451-9. PubMed ID: 26980726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia.
    Mrózek K; Marcucci G; Nicolet D; Maharry KS; Becker H; Whitman SP; Metzeler KH; Schwind S; Wu YZ; Kohlschmidt J; Pettenati MJ; Heerema NA; Block AW; Patil SR; Baer MR; Kolitz JE; Moore JO; Carroll AJ; Stone RM; Larson RA; Bloomfield CD
    J Clin Oncol; 2012 Dec; 30(36):4515-23. PubMed ID: 22987078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis and monitoring of core-binding factor acute myeloid leukemia: current and emerging factors.
    Duployez N; Willekens C; Marceau-Renaut A; Boudry-Labis E; Preudhomme C
    Expert Rev Hematol; 2015 Feb; 8(1):43-56. PubMed ID: 25348871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis.
    Okuda T; van Deursen J; Hiebert SW; Grosveld G; Downing JR
    Cell; 1996 Jan; 84(2):321-30. PubMed ID: 8565077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.
    Döhner H; Estey E; Grimwade D; Amadori S; Appelbaum FR; Büchner T; Dombret H; Ebert BL; Fenaux P; Larson RA; Levine RL; Lo-Coco F; Naoe T; Niederwieser D; Ossenkoppele GJ; Sanz M; Sierra J; Tallman MS; Tien HF; Wei AH; Löwenberg B; Bloomfield CD
    Blood; 2017 Jan; 129(4):424-447. PubMed ID: 27895058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RUNX1 and RUNX1-ETO: roles in hematopoiesis and leukemogenesis.
    Lam K; Zhang DE
    Front Biosci (Landmark Ed); 2012 Jan; 17(3):1120-39. PubMed ID: 22201794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis.
    Wang Q; Stacy T; Binder M; Marin-Padilla M; Sharpe AH; Speck NA
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3444-9. PubMed ID: 8622955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Importance of C-KIT Mutations in Core Binding Factor Acute Myeloid Leukemia: A Systematic Review.
    Ayatollahi H; Shajiei A; Sadeghian MH; Sheikhi M; Yazdandoust E; Ghazanfarpour M; Shams SF; Shakeri S
    Hematol Oncol Stem Cell Ther; 2017 Mar; 10(1):1-7. PubMed ID: 27613372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The genomic landscape of core-binding factor acute myeloid leukemias.
    Faber ZJ; Chen X; Gedman AL; Boggs K; Cheng J; Ma J; Radtke I; Chao JR; Walsh MP; Song G; Andersson AK; Dang J; Dong L; Liu Y; Huether R; Cai Z; Mulder H; Wu G; Edmonson M; Rusch M; Qu C; Li Y; Vadodaria B; Wang J; Hedlund E; Cao X; Yergeau D; Nakitandwe J; Pounds SB; Shurtleff S; Fulton RS; Fulton LL; Easton J; Parganas E; Pui CH; Rubnitz JE; Ding L; Mardis ER; Wilson RK; Gruber TA; Mullighan CG; Schlenk RF; Paschka P; Döhner K; Döhner H; Bullinger L; Zhang J; Klco JM; Downing JR
    Nat Genet; 2016 Dec; 48(12):1551-1556. PubMed ID: 27798625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.